Literature DB >> 20019240

Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis.

Byeong-Seon Jeong1, Wenwei Hu, Vladimir Belyi, Raul Rabadan, Arnold J Levine.   

Abstract

Human populations contain a functional coding polymorphism (codon 72) in the p53 gene. To explore whether this polymorphism alters the transcriptional pattern of p53-regulated genes, the human isogenic cell lines harboring p53 with either the proline or arginine at codon 72 were employed to activate p53-mediated transcription. Thirty-four p53-regulated genes were assayed for their increased levels of mRNA using quantitative real-time PCR. The largest difference between p53-arginine and p53-proline was found with the PERP gene involved in cell-cell adhesion and apoptosis. The most common set of genes that are transcribed better by the p53-arginine protein than the p53-proline protein was found in the apoptotic function (DR-4, NOXA, PUMA, and PIG-3). LIF, a cytokine that is required for optimal reproductive function, was produced at 2x higher levels by the p53-arginine than the p53-proline allele. The genes that induced their mRNAs at the highest levels compared to the baseline tended to be synthesized better by the p53-arginine protein than the p53-proline protein. These molecular studies may help to explain the complicated associations observed between this polymorphism and the incidence of some cancers, the longevity of some populations, and the fecundity of different groups.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20019240     DOI: 10.1096/fj.09-146001

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  27 in total

1.  The Regulation of Aging and Longevity: A New and Complex Role of p53.

Authors:  Zhaohui Feng; Meihua Lin; Rui Wu
Journal:  Genes Cancer       Date:  2011-04

2.  TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.

Authors:  Natalia Volodko; Mohamed Salla; Bertus Eksteen; Richard N Fedorak; Hien Q Huynh; Shairaz Baksh
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

3.  A minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activity.

Authors:  Sylwia Kabacik; Ana Ortega-Molina; Alejo Efeyan; Paul Finnon; Simon Bouffler; Manuel Serrano; Christophe Badie
Journal:  Cell Cycle       Date:  2011-04-01       Impact factor: 4.534

4.  Regulation of female reproduction by p53 and its family members.

Authors:  Zhaohui Feng; Cen Zhang; Hey-Joo Kang; Yvonne Sun; Haijian Wang; Asad Naqvi; Amanda K Frank; Zev Rosenwaks; Maureen E Murphy; Arnold J Levine; Wenwei Hu
Journal:  FASEB J       Date:  2011-03-14       Impact factor: 5.191

5.  The codon 72 polymorphism of p53 regulates interaction with NF-{kappa}B and transactivation of genes involved in immunity and inflammation.

Authors:  Amanda K Frank; Julia I-Ju Leu; Yan Zhou; Karthik Devarajan; Tatiana Nedelko; Andres Klein-Szanto; Monica Hollstein; Maureen E Murphy
Journal:  Mol Cell Biol       Date:  2011-01-18       Impact factor: 4.272

6.  MiR-1246: a new link of the p53 family with cancer and Down syndrome.

Authors:  Jun-Ming Liao; Xiang Zhou; Yu Zhang; Hua Lu
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

7.  Transcriptomes and shRNA suppressors in a TP53 allele-specific model of early-onset colon cancer in African Americans.

Authors:  Charles C Weige; Marc R Birtwistle; Himel Mallick; Nengjun Yi; Zuzana Berrong; Emily Cloessner; Keely Duff; Josephine Tidwell; Megan Clendenning; Brent Wilkerson; Christopher Farrell; Fred Bunz; Hao Ji; Michael Shtutman; Kim E Creek; Carolyn E Banister; Phillip J Buckhaults
Journal:  Mol Cancer Res       Date:  2014-04-17       Impact factor: 5.852

Review 8.  Genetic Modifiers of the p53 Pathway.

Authors:  Subhasree Basu; Maureen E Murphy
Journal:  Cold Spring Harb Perspect Med       Date:  2016-04-01       Impact factor: 6.915

9.  Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion.

Authors:  Shabirul Haque; Xiao Jie Yan; Lisa Rosen; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  FASEB J       Date:  2013-10-21       Impact factor: 5.191

10.  The Pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer risk.

Authors:  Katharina Proestling; Alexandra Hebar; Nina Pruckner; Erika Marton; Ursula Vinatzer; Martin Schreiber
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.